Weiss Multi-Strategy Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$317K 520
2023
Q4
$317K Sell
1,000
-9,000
-90% -$1.75M 0.01% 489
2023
Q3
$1.69M Buy
+10,000
New +$1.88M 0.04% 392
2023
Q1
Sell
-3,000
Closed -$590K 765
2022
Q4
$590K Buy
+3,000
New +$643K 0.02% 500

Other funds holding KRTX

Weiss Multi-Strategy Advisers's KRTX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,000 shares — an estimated $317K sold.

Weiss Multi-Strategy Advisers first reported a position in KRTX in Q4 2022 and held it in 3 quarters. The position peaked at $1.69M in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $317K.
  • Weiss Multi-Strategy Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $1.69M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.